Murine thrombin lacks Na+ activation but retains high catalytic activity

被引:35
作者
Bush, LA [1 ]
Nelson, RW [1 ]
Di Cera, E [1 ]
机构
[1] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.M512082200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human thrombin utilizes Na+ as a driving force for the cleavage of substrates mediating its procoagulant, prothrombotic, and signaling functions. Murine thrombin has Asp-222 in the Na+ binding site of the human enzyme replaced by Lys. The charge reversal substitution abrogates Na+ activation, which is partially restored with the K222D mutation, and ensures high activity even in the absence of Na+. This property makes the murine enzyme more resistant to the effect of mutations that destabilize Na+ binding and shift thrombin to its anticoagulant slow form. Compared with the human enzyme, murine thrombin cleaves fibrinogen and protein C with similar k(cat)/K-m values but activates PAR1 and PAR4 with k(cat)/K-m values 4- and 26-fold higher, respectively. The significantly higher specificity constant toward PAR4 accounts for the dominant role of this receptor in platelet activation in the mouse. Murine thrombin can also cleave substrates carrying Phe at P1, which potentially broadens the repertoire of molecular targets available to the enzyme in vivo.
引用
收藏
页码:7183 / 7188
页数:6
相关论文
共 62 条
[21]   Molecular mechanisms of thrombin function [J].
DiCera, E ;
Dang, QD ;
Ayala, YM .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1997, 53 (09) :701-730
[22]   Theory of allosteric effects in serine proteases [J].
DiCera, E ;
Hopfner, KP ;
Dang, QD .
BIOPHYSICAL JOURNAL, 1996, 70 (01) :174-181
[23]   THE NA+ BINDING-SITE OF THROMBIN [J].
DICERA, E ;
GUINTO, ER ;
VINDIGNI, A ;
DANG, QD ;
AYALA, YM ;
WUYI, M ;
TULINSKY, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22089-22092
[24]   The structure of the potassium channel:: Molecular basis of K+ conduction and selectivity [J].
Doyle, DA ;
Cabral, JM ;
Pfuetzner, RA ;
Kuo, AL ;
Gulbis, JM ;
Cohen, SL ;
Chait, BT ;
MacKinnon, R .
SCIENCE, 1998, 280 (5360) :69-77
[25]   Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays [J].
Gosalia, DN ;
Salisbury, CM ;
Maly, DJ ;
Ellman, JA ;
Diamond, SL .
PROTEOMICS, 2005, 5 (05) :1292-1298
[26]   The thrombin mutant W215A/E217A shows safe and potent anticoagulant and antithrombotic effects in vivo [J].
Gruber, A ;
Cantwell, AM ;
Di Cera, E ;
Hanson, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) :27581-27584
[27]   Unexpected crucial role of residue 225 in serine proteases [J].
Guinto, ER ;
Caccia, S ;
Rose, T ;
Fütterer, K ;
Waksman, G ;
Di Cera, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :1852-1857
[28]   Prothrombin Greenville, Arg517→Gln, identified in an individual heterozygous for dysprothrombinemia [J].
Henriksen, RA ;
Dunham, CK ;
Miller, LD ;
Casey, JT ;
Menke, JB ;
Knupp, CL ;
Usala, SJ .
BLOOD, 1998, 91 (06) :2026-2031
[29]   A dual thrombin receptor system for platelet activation [J].
Kahn, ML ;
Zheng, YW ;
Huang, W ;
Bigornia, V ;
Zeng, DW ;
Moff, S ;
Farese, RV ;
Tam, C ;
Coughlin, SR .
NATURE, 1998, 394 (6694) :690-694
[30]   TITRATION OF ACTIVE CENTERS IN THROMBIN SOLUTIONS . STANDARDIZATION OF ENZYME [J].
KEZDY, FJ ;
LORAND, L ;
MILLER, KD .
BIOCHEMISTRY, 1965, 4 (11) :2302-&